Onconetix, Inc. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$304K↓-57.4%
2025-09-30$304K↓-25.4%$-9M↓-129.5%-681.5%
2025-06-30$106K↓-84.9%$-2M↑+83.4%-1817.4%
2025-03-31$102K↓-85.5%$-9M↑+23.1%-12369.2%
2024-12-31$712K
2024-09-30$407K$-4M↑+28.4%-650.3%
2024-06-30$705K$-14M↓-108.4%-1931.6%
2024-03-31$700K$-11M↓-290.6%-1582.2%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$304K
↓-57.4% -$408K YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 20 quarters

margin trajectory tells the operating-leverage story
Gross Margin↓-11.1pts
81.6%
Operating Margin↓-31.1pts
-681.5%
Net Margin↓-1952.0pts
-2892.7%

Go deeper